Effect of fezolinetant treatment on patient-reported sleep disturbance: pooled data from two Phase 3 studies in women with moderate-to-severe vasomotor symptoms associated with menopause

被引：0

作者：

Marla Shapiro, C. M. ^{[1
]}

Cano, Antonio ^{[2
]}

Nappi, Rossella E. ^{[3
]}

Santoro, Nanette F. ^{[4
]}

English, Marci ^{[5
]}

Mancuso, Shayna ^{[5
]}

Morga, Antonia ^{[6
]}

Siddiqui, Emad ^{[6
]}

Valluri, Udaya ^{[5
]}

Ottery, Faith D. ^{[5
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

[2] Univ Valencia, Valencia, Spain

[3] Univ Pavia, Fdn Policlin IRCCS S Matteo, Pavia, Italy

[4] Univ Colorado, Sch Med, Aurora, CO USA

[5] Astellas Pharma Global Dev, Northbrook, IL USA

[6] Astellas Pharma Europe Ltd, Addlestone, Surrey, England

来源：

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2022年 / 29卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

P-74

引用

页码：1484 / 1484

页数：1